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Intracellular bacterial pathogens, such as the agents of Legionnaires' disease,
tuberculosis, leprosy, and psittacosis, multiply within and destroy host mononu-
clear phagocytes. The receptors on the mononuclear phagocytes and the ligands
on the bacteria mediating uptake of these human pathogens have not been
described.
In this study, we have examined receptors involved in the phagocytosis of
Legionella pneumophila, an intracellular bacterial pathogen that multiplies in
human monocytes and alveolar macrophages (1, 2) and causes Legionnaires'
disease. Monocytes phagocytize L. pneumophila by an unusual process termed
"coiling phagocytosis" in which pseudopods coil around the organism as it is
internalized (3). After entry into monocytes, L. pneumophila is enclosed within a
specialized phagosome, formation ofwhich involves the sequential interaction of
the phagosome with monocyte smooth vesicles, mitochondria, and ribosomes (4).
L. pneumophila multiplies in these phagosomes, which do not fuse with lysosomes
(5) nor undergo normal acidification (6). L. pneumophila multiplies intraphago-
somally until the monocyte ruptures.
We report in this paper that monocyte complement receptors (CR),' CR1 and
CR3, mediate phagocytosis of L. pneumophila; mAbs against these receptors
inhibit adherence of L. pneumophila to monocytes and, subsequently, the ability
to enter monocytes and multiply intracellularly.
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Materials and Methods
Media.
￿
Charcoal yeast extract agar, egg yolk buffer with or without I% BSA, and
RPMI 1644 were made or purchasedas described (1). No antibiotics were used in the cell
cultures.
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E-C3b, C3b-coated sheep erythrocytes; E-C3bi: C3bi-coated
sheep erythrocytes; E-IgG: IgG-coated sheep erythrocytes; HSA, human serum albumin; CR3,
complement receptor type 3; CR1, complement receptor type 1.
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Reagents.
￿
Mannan (No. 3640, Sigma Chemical Co., St. Louis, MO) was suspended at
40 mg/ml and used at a final concentration of 4-6 mg/ml in adherence assays. Human
fibronectin (M, 440,000, No. 341635; Calbiochem-Behring Corp., La Jolla, CA) was
added to monocyte monolayers in selected experiments at a final concentration of 200
ug/ml.
Sera.
￿
Sera from immune and nonimmune adult volunteers were separated, filtered,
stored, and handled in such a manner as to preserve complement activity (4). When
required, complement was inactivated by incubating at 56° C for 30 min. Nonimmune
sera had an indirect fluorescent antibody titer of :51 :64 (4); immune sera had a titer of
1 :512 .
Monocytes.
￿
Mononuclear cells were isolated from heparinized blood on Ficoll-sodium
diatrizoate gradients, and the monocyte fraction was cultured in 16-mm diameter flat-
bottomed wells (Linbro; Flow Laboratories, Inc., McLean, VA) or on No. 2 glass cover
slips in RPMI 1640 with 20% autologous or AB, nonimmune serum (1, 7). Monolayers
contained ^-105 monocytes per coverslip or culture dish well. In experiments designed to
modulate Fc receptors, mononuclear cell suspensions were prepared as above, diluted to
a concentration of 3 X 106 cells/mm', cultured for 24 h in Teflon wells (Savillex Corp.
Minnetonka, MN), and plated on antigen-antibody-coated or control cover slips.
Bacteria.
￿
L. pneumophila, Philadelphia 1 strain, was grown in embryonated hens' eggs,
passed once only on charcoal yeast extract agar, and suspended at the working concentra-
tion in egg yolk buffer (1).
Antibodies. mAbs anti-CRI, anti-CRII, anti-transferrin receptor (Becton Dickinson
Immunocytometry Systems, Mountain View, CA), and OKM-1 (Ortho Diagnostic Systems
Inc., Westwood, MA), were purchased. mAb OKM-10 was generously provided by Dr.
Gideon Goldstein, Ortho Pharmaceuticals, Raritan, NJ. mAb D-12 (equivalent to Becton
Dickinson's Leu-15) in ascitic fluid was generously donated by Dr. Loran Clement,
Department of Pediatrics, UCLA School of Medicine. mAbs OKM-1 (IgG2b), OKM-10
(IgG2), and D-12 (IgG2a) are all directed against the CR3 receptor for C3 fragments (8-
10). Anti-CRI (IgG I) is directed against the C3b or CRI receptor (11), anti-CRII (IgG2a)
is directed against the C3d or CR2 receptor (12), anti-transferrin receptor (IgG2a) is
directed against the human transferrin receptor (13), and anti-DR (IgG2a) is directed
against the DR antigen (13) . All commercially obtained mAbs were dialyzed twice against
?100 volumes of PBS to remove azide.
FITC-labeled anti-C3 and anti-IgG were purchased from Atlantic Antibodies, Scarbor-
ough, ME. Rabbit anti-sheep RBC IgG was the generous gift of Dr. Samuel Wright, The
Rockefeller University, New York. FITC anti-L. pneumophila rabbit Ig was obtained from
the Centers for Disease Control, Atlanta, GA (lot 82-0073). Nonspecific mouse IgG was
obtained from Cappel Laboratories, Malvern, PA.
Assayfor Inhibition of L. pneumophila Adherence to Monocytes by mAbs.
￿
Monocyte mon-
olayers were cultured on plain glass coverslips in RPMI medium containing either 20%
heat-inactivated, or 20% fresh serum at 37 ° C in 5% C02-95% air for 24 h and then
incubated at 37°C for 30 min with various mAbs in concentrations varying from 0.5 to
>50 pg/ml. Then, 10' CFU of L. pneumophila were added to the monolayer (bacte-
ria/monocyte ratio, 200:1) and the mixture was incubated at 100 rpm on a rotating
platform at 37°C for 60 min in 5% C02-95% air. The monolayers were then washed
vigorously and fixed in 10% formalin. L. pneumophila were stained with fluorescein-
labeled anti-L. pneumophila antibody and the percentage of monocytes with ? 1 adherent
bacterium and the average number of bacteria per monocyte on each cover slip were
determined by counting a minimum of 200 monocytes per cover slip under fluorescence
microscopy (Fluophot; Nikon, Tokyo, Japan).
In selected experiments, monocytes were incubated with L. pneumophila in the absence
of serum, in which case 10-20 mM Hepes was added to the medium. In experiments
requiring preopsonization of bacteria, L. pneumophila were opsonized in 20% fresh,
nonimmune serum, washed twice in RPMI,and resuspended to the original concentration
before addition to the monocyte monolayer. In some of these experiments, preopsonized
bacteria were heat-treated for 30 min at 56 °C before addition to monocytes.PAYNE AND HORWITZ
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Assayfor Modulation ofMonocyte CR1, CR3, and Fc Receptors.
￿
Cover slips coated with
L. pneumophila or Escherichia coli membranes were prepared by adhering the membranes,
isolated as described (14), to glass cover slips by the method of Michl et al. (15) using
poly-L-lysine (70,000 M,; Sigma Chemical Co.) and 2.5% glutaraldehyde. Control cover
slips were prepared the same way but without bacterial membranes. IgG-coated sheep
erythrocytes (E-IgG) were prepared by incubatinga 5% suspension of washed erythrocytes
at 37'C for 30 min with an equal volume of rabbit anti-sheep IgG diluted 1 :199 in PBS
without calcium and magnesium. Erythrocytes coated with C3b (E-C3b) or C3bi (E-C3bi)
were prepared as described (16).
Monocytes were plated on coverslips coated with bacterial membranes or on control
coverslipsand incubated with E-IgG, E-C3b, or E-C3bi at an erythrocytes/monocyte ratio
of 80:1 at 37'C for 90 min without agitation in the presence of heat-inactivated serum.
The monocytes were washed and the number of E-C3b or E-C3bi bound to monocytes or
the number of E-IgG bound or ingested by monocytes was enumerated. Ingested E-IgG
were enumerated after hypotonic lysis of extracellular E-IgG. At least 200 monocytes on
each of duplicate or triplicate cover slips were evaluated.
In separate experiments designed to assess the importance of the Fc receptor to
phagocytosis of L. pneumophila, monocytes were plated on coverslips coated with antigen-
antibody complexes. Human serum albumin (HSA; Calbiochem-Behring Corp.) at 1
mg/ml was attached to No. 2 glass coverslips using the method of Michl et al. (15),
followed by blocking of unreacted sites with 0.2 M glycine in 0.01 M sodium-phosphate
buffer (pH 7.2), washing with PBS, and finally the addition of rabbit anti-HSA at 1 mg/ml
for 30 min. The coverslips were then washed with RPMI and monocytes were allowed to
attach for 60 min at 37 °C. Control coverslips were coated with HSA alone.
Assay for Intracellular Multiplication of L. pneumophila.
￿
Monocyte monolayers were
cultured for 24 or 48 h in 20% heat-inactivated, AB, nonimmune serum and then
incubated at 37°C for 30 min in 5% C02-95% air with or without mAbs (11 wg/ml) or
mouse IgG (168 Ag/ml). The cultures were infected with L. pneumophila (104 CFU) and
assayed for CFU daily for 3 d. Monolayers were also inspected daily for evidence of cell
damage.
In selected experiments designed to evaluate the influence of mAbs on multiplication
of intracellular L. pneumophila, anti-CR3 was added after the monocytes were infected
with L. pneumophila rather than before. Monocytes were infected, washed to remove
extracellular bacteria, and treated with anti-CR3 (11 Ag/ml).
Electron Microscopy.
￿
Fresh monocytes treated with anti-CR3, anti-CR1, or anti-HLA-
DR at a concentration of 20,ug/ml for 30 min at 37 °C, were washed and then combined
with L. pneumophila at a bacteria/monocyte ratio of 1,000:1 in the presence of fresh
nonimmune serum. The samples and a control specimen with monocytes not exposed to
mAbs were then incubated and prepared for electron microscopy as described (3). At
least 100 monocytes from each sample were examined.
Statistical Analysis. Mean, standard deviation, standard error, and t-statistics were
calculated using standard formulas.
Results
Monocyte CR1 and CR3 Receptors Mediate Adherence of L. pneumophila.
￿
To
determine if any of several known monocyte receptors, and in particular com-
plement receptors, mediate adherence of L. pneumophila, we examined the
capacity of mAbs against several monocyte receptor antigens to inhibit the
adherence of live L. pneumophila to monocytes in monolayer culture. A repre-
sentative experiment is shown in Table I and cumulative data using eight mAbs
is shown in Table II. mAbs against the CR3 and CR1 receptors, which recognize
C3bi and C3b, respectively, strongly and consistently inhibited L. pneumophila
adherence to monocytes. Anti-CR3 antibodies D-12 (Leu-15), OKM-1, and
OKM-10 inhibited L. pneumophila adherence by 64-74% and anti-CR1 antibod-1380
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TABLE I
mAbs Against CRI and CR3 Receptors Inhibit L. pneumophila Adherence to Monocytes
Monocytes in monolayer culture on coverslips were incubated with L. pneumophila in the presence
of the mAbs indicatedat a concentration of 11 tag/ml or without mAb (control). The percentage of
monocyteswith adherent bacteria andtheaveragenumber ofbacteria per monocyte were determined
by fluorescence microscopy. Data are the mean ofduplicateor triplicate coverslips.
TABLE II
Inhibition ofLegionella pneumophila adherence to Monocytes by mAbs
L. pneumophila adherence to monocytesin thepresence of thevarious mAbs indicated was assayed
as in Table I. The mAbs were used at a concentration of I 1 ug/ml, and the mouse IgG was used
at a concentration of 168,ug/ml. Data foreach antibody are the mean inhibition of L. pneumophila
adherence ± SE obtained in two to nine independent experiments, each of which was done in
duplicateor triplicate.
* Percent decrease in mean number of L. pneumophila per monocyte from control monocytes
incubated withoutantibody.
ies inhibited by 68% (Table II). In most experiments, a combination of anti-CR3
and anti-CRI antibodies resulted in little or no greater inhibition (mean 73%)
than anti-CR3 or anti-CRI antibody alone. mAbs against the DR antigen, the
CR2 receptor (17, 18) and the transferrin receptor, and nonspecific mouse IgG
had only modest effects on L. pneumophila adherence (average inhibition 12-
29%, Table II).
The IgG subtypewas not relevant to the capacity of mAbs to inhibitadherence.
The three anti-CR3 antibodies, all of which strongly inhibited adherence, were
of two different subtypes (2a and 2b). mAbs against the HLA-DR antigen,
Monoclonal an-
tibody Target antigen
Monocytes with
?1 adherent L
pneumophila ± SD
Mean number L.
pneumo-
phila/monocyte ±
SD
Inhibition of
adherence
(decrease
from control)
%
None (Control) 81 .0 ± 0.1 3.29t 0.42 0
D-12 (Leu 15) CR3 32.1 ± 6.6 0.60 ± 0.10 82
Anti-CRI CRI 42.0 ± 2.3 0.97 ± 0.02 71
Anti-CRI/D-12 CRI & CR3 22.7 ± 4.1 0.37 ± 0.15 89
Anti-transfer- Human transferrin 77.0 ± 5.8 2.75 ± 0.84 16
rin receptor receptor
Anti-CRII CR2 78.1 ± 0.2 3.02 t 0.20 8
Monoclonal antibody Target antigen Ig Subtype
Inhibition of
L. pneumophila
adherence
(Mean t SE)*
%
D-12 (Leu-15) CR3 IgG2a 74 ± 7
OKM-10 CR3 IgG2 67 ± 12
OKM-I CR3 IgG26 64 ± 8
Anti-CRI CRI IgGI 68 ± 1
Anti-CRI/D-12 CRI/CR3 IgGI/IgG2a 73 t 9
Anti-transferrin receptor Human transferrin receptor IgG2a 29 ± 7
Anti-CRII CR2 IgG2a 16 ± 6
Anti-HLA-DR HLA-DR IgG2a 12 ± 9
Mouse IgG Nonspecific - 16±7e0 w
c 60
a
0 40
0
~ 20 m
= 0
r 1
￿
2
￿
5
￿
7
TIME MONOCYTES IN CULTURE (Days I
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FIGURE 1 .
￿
Capacity of anti-CR3 mAb (D-12) to inhibit
the adherence of L. pneumophila to monocytes kept in
culture for various lengths of time. Monocytes were cul-
tured for 1, 2, 5, or 7 d and incubated with anti-CR3
antibody at the concentration indicated above the bars
for30 minutes at 37°C, and infected with L. pneumophila
as notedin Tables IandII. 11 wg/mlofanti-CR3 strongly
inhibited L. pneumophila adherence to monocytes cul-
tured for 1 or 2 d but not 5 or 7 d. A higher dose, 33
Fig/ml, was required to inhibit strongly adherence to
monocytescultured for 7 d. Results arerepresentative of
two separate assays each done in duplicate or triplicate.
transferrin receptor, and CR2 receptor that had minimal effects on adherence,
were of the same subtype (IgG2a) as anti-CR3 antibody D-12, which had the
strongest inhibitory effect on adherence.
Anti-CR3 antibodies inhibited L. pneumophila in a dose-dependent fashion and
at relatively low concentrations. As little as 1 ug/ml of D-12 and 2 ug/ml of
OKM-10 inhibited adherenceby 67 and 88%, respectively. Theinhibitory effects
plateaued at 5-10,ug/ml with all three anti-CR3 antibodies, and did not increase
above 90% inhibition even with concentrations of D-12 or OKM-10 of ?80
The anti-CR3 receptor antibodies were not lethal to monocytes. After incu-
bation with as high a concentration as 44 jAg/ml of D-12, 98% of monocytes
excluded trypan blue. Moreover, anti-CR3 receptor antibodies did not inhibit
monocyte ingestion of L. pneumophila when the bacteria were coated with
antibody and complement (see below).
Specific antibody in the presence ofcomplement greatly enhances phagocytosis
of L. pneumophila by monocytes (19). Interestingly, mAb against the monocyte
CR3 receptor inhibited binding of such antibody-coated bacteria to monocytes
by only 12 ± 8% (mean ± SE) in the presence offresh serum. One explanation
for this may be that monocyte receptors for the Fc portion of Ig are able to
mediate adherence of such antibody-coated bacteria. Alternatively, the amount
of C3 fixed to the bacteria in the presence of specific antibody may be great
enough to overcome the CR3 receptor inhibition induced by the mAbs.
Monocyte monolayers cultured for 7 d required more anti-CR3 mAb than did
monolayers cultured for 1 d to achieve the same degree of inhibition of L.
pneumophila adherence (Fig. 1). Whereas 11 tLg/ml ofanti-CR3 antibody inhib-
ited L. pneumophila adherence to monocytes cultured for 1 d by 56% and for 2
d by 74%, thisamount ofanti-CR3 antibody inhibited L. pneumophila adherence
to monocytes cultured for 7 d by only 13% in the same experiment. Increasing
the amount of anti-CR3 antibody to 33 gg/ml resulted in 74% inhibition of L.
pneumophila adherence to 7-dmonocytes, similar to that seen with 1-d monocytes
(Fig. 1). The amount of anti-CR1 antibody required to inhibit L. pneumophila
adherence was not different in monocytes cultured for 1 or 7 d.
We used electron microscopy to determine ifanti-CR3 altered coiling phago-
cytosis or resulted in an increased number ofattached but uningested bacteria.
The decreased number of bacteria ingested by monocytes in the presence of
anti-CR3 were still ingested by coiling phagocytosis, which did not differ quali-
tatively from that seen in control specimens or from that reported previously1382 PHAGOCYTOSIS OF LEGIONELLA PNEUMOPHILA
TABLE III
Modulation ofFc Receptors by Antigen-Antibody Complexes Does Not Significantly Reduce
Legionella pneumophila Attachment
Monocytes were plated on a substrate of antigen-antibody complexes (HSA/anti-HSA) or on
antigen alone (HSA) as a control, incubated with IgG-coated erythrocytes, IgG-coated L. pneumo-
phila (bacteria preopsonized in high-titer immune serum) or L. pneumophila not coated with
detectable IgG (bacteria preopsonized in nonimmune serum lacking detectable antibody), and
assayedforassociated RBCor L. pneumophila as describedin MaterialsandMethods. Data represent
the mean of duplicate measurements. Monocytes plated on antigen-antibody complexes displayed
a marked reduction in capacity to bind or ingest IgG-coated RBC (columns 4-6) or IgG-coated L.
pneumophila (column 3), but only a slight reduction in capacity to bind L. pneumophila not coated
with IgG (column 2). This experiment is representative ofthree independent experiments.
* IFA titer = 1:20,000. Serum washeated at 56 °C for 60 min before use.
$ Human serumalbumin.
(4). In the presence of anti-CR3 there was no increase in the proportion of
bacteria that were attached but not ingested, suggesting that anti-CR3 inhibits
phagocytosis primarily by decreasing adherence to the monocytes.
The role ofFc receptors was thought to be small in these experimentsin which
bacteria were opsonized in nonimmune sera. To confirm this, we investigated
the influence of modulating monocyte FcR on L. pneumophila adherence to
monocytes. We modulated FcR by plating monocytes on antigen-antibody com-
plexes consisting of HSA and anti-HSA. Whereas monocytes plated on antigen-
antibody complexes bound or ingested 87 ± 8.1 % fewer E-IgG, such monocytes
bound only 28 ± 5.5% fewer L. pneumophila than did control monolayers plated
on HSA alone (Table III). The small decrease in L. pneumophila adherence after
FcR modulation confirmed that FcR play little role in the phagocytosis of L.
pneumophila after opsonization with nonimmune serum.
Mannan at 4-6 mg/ml final concentration did not significantly inhibit L.
pneumophila adherence to monocytes (28 ± 16% inhibition). Addition of fibro-
nectin at a final concentration of 200 /Ag/ml did not increase unopsonized L.
pneumophila adherence.
L. pneumophila Membrane Substrates Modulate Monocyte CRI and CR3 Receptors
and Monocyte Phagocytosis ofL. pneumophila. To furtherexamine the interaction
between the L. pneumophila surface and monocyte CRI and CR3 receptors, we
plated monocytes on L. pneumophila membrane substrates and examined the
capacity of these monocytes to bind complement-coated erythrocytes. We rea-
soned that if L. pneumophila binds to monocyte CRI and CR3 receptors, the
CRI and CR3 receptors of monocytes plated on L. pneumophila membrane
substrates would migrate to the undersurface ofthe monocyte and be unavailable
for binding C3b and C3bi-coated erythrocytes. Indeed, monocytes plated on L.
pneumophila membrane substrates bound 70 ± 15% fewer C3b-coated erythro-
Substrate
L. pneumophila
Bacteria
preopsonized
in nonimmune
fresh serum
per monocyte
Bacteria
preopsonized
in immune
heated serum*
IgG-coated
Ingested
sheep RBCper
Rosetted
monocyte
Total
HSA$ 0.22 0.88 1.53 2.65 4.18
HSA/Anti-HSA 0.15 0.21 0.04 0.75 0.79
Percent Reduction 32% 76% 97% 72% 81PAYNE AND HORWITZ
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TABLE IV
L. pneumophila Membrane Substrates Modulate Monocyte CRI and CR3 Receptors
Monocytes were cultured on coverslips coated with L. pneumophila membrane substrates or on
control coverslips and then incubated with E-C3b, E-C3bi, or E-IgG. Themonocytes were washed
to remove nonadherent erythrocytes, and the number of erythrocytes of each type bound per
monocyte and the number of E-IgG ingested per monocyte were enumerated. Data are the mean
for duplicate or triplicate coverslips; 200-600 monocytes per coverslip were enumerated.
* Mean number of erythrocytes per monocyte ±SD.
cytes and 53 ± 23% fewer C3bi-coated erythrocytes than control monocytes
(Table IV). In contrast, monocytes bound to L. pneumophila substrates and
control monocytes bound and ingested comparable numbers of IgG-coated
erythrocytes, indicating that the L. pneumophila membranes do not induce a
generalized inhibition of adherence or phagocytosis.
L. pneumophila membrane substrates also modulate the ability of monocytes to
phagocytize live L. pneumophila. Monocytes plated on these substrates bound
87-92% fewer live L. pneumophila than control monolayers. For example, in a
representative experiment, control monocytes bound 0.43 bacteria per mono-
cyte, monocytes plated on E. coli (K-12) membranes bound 0.39 bacteria per
monocyte, whereas monocytes plated on L. pneumophila membranes bound only
0.04 bacteria per monocyte, a reduction of >1 log, o.
L. pneumophila Adherence Correlates with Fixation of Complement Component C3
to the Bacterial Surface. The finding that complement receptors CRI and CR3
mediate L. pneumophila adherence implied a role for C3 or a C3-like molecule
on the L. pneumophila surface. To investigate this, we first measured adherence
of L. pneumophila in the presence of fresh serum, heat-inactivated serum, or no
serum (Table V). Adherence of L. pneumophila was markedly reduced in heat-
inactivated serum (84% reduction) or in the absence of serum (97% reduction;
Table V) .
To confirm that this reduction in adherence was due to the absence of an
opsonin on the bacterial surface, we examined the adherence of L. pneumophila
Exp. Monocytes
Monocyte
E-C3b
bindingof E-C3b, E-C3bi, and
ingestion of E-IgG*
Bound
E-C3bi E-IgG
E-IgG and
Ingested
E-IgG
1 Control monocytes 1.58 ± 0.11 0.18 ± 0.08 1.19 t 0.19 1.97 ± 0.60
Monocytesplated on L. pneumo- 0.35 ± 0.01 0.07 ± 0.05 0.76 t 0.23 1.60 ± 0.47
phila membranes
2 Control monocytes 0.53 f0.30 0.10 t 0.02 1.96 t 0.01 2.90 t 0.33
Monocytesplated on L. pneumo- 0.05 f 0.08 0.03 t 0.01 1.78 t 0.84 2.04 ± 0.09
philamembranes
3 Control monocytes 1.42 t 0.65 0.60 ± 0.12 0.43 ± 0.18 3.20 ± 0.05
Monocytesplated on L. pneumo- 0.83 t0.22 0.44 ± 0.06 0.50 ± 0.13 2.99 ± 0.15
philamembranes
Mean percent inhibition from 70 t 15 53 t 23 13 ± 22 19 ± 12
control t SD1384 PHAGOCYTOSIS OF LEGIONELLA PNEUMOPHILA
TABLE V
Complement Fixation Correlates with Adherence ofL. pneumophila to
Monocytes: Adherence ofL. pneumophila to Monocytes in Fresh, Heat-
inactivated, and No Serum
Monocytes in monolayer culture were incubated with L. pneumophila in
the presence of fresh, heat-inactivated, or no serum and the mean
number of adherent bacteria per monocyte was enumerated. Data are
the mean ± SD for triplicate coverslips; at least 200 monocytes per
coverslip were enumerated.
* Percent decrease in mean number of bacteria per monocyte for L.
pneumophila incubated in heat-inactivated or no serum in comparison to
L. pneumophila incubated in freshserum.
TABLE VI
Complement Fixation Correlates with Adherence ofL. pneumophila to
Monocytes: Adherence ofPreopsonized and Unopsonized L.
pneumophila to Monocytes in the Presence ofHeat-inactivated Serum
Monocytes were incubated with preopsonized or unopsonized L. pneu-
mophila in the presence of heat-inactivated serum and the number of
adherent bacteria permonocyte wasenumerated as above. Preopsonized
L. pneumophila were obtained by incubating the bacteria in fresh non-
immune serumand washingthem. Data arethemean t SD fortriplicate
coverslips; at least 200 monocytes percoverslip were enumerated.
* Percent decrease in mean number of bacteria per monocyte for unop-
sonized L. pneumophila in comparison to preopsonized L. pneumophila.
that were preopsonized. L. pneumophila were incubated in fresh nonimmune
serum, vigorously washed, and then added to the monocytes in the presence of
heat-inactivated serum. Such preopsonized L. pneumophila were readily bound
by monocytes (Table VI). In contrast, unopsonized L. pneumophila that were
incubated with monocytes under the same conditions were poorly bound; adher-
ence of unopsonized L. pneumophila was 18-fold less than that of preopsonized
bacteria. Thus monocytesappeared to phagocytizeL. pneumophila veryefficiently
in heat-inactivated serum, provided the bacteria were preopsonized.
These studies suggested that adherence of L. pneumophila to monocytes was
dependent on the deposition of a serum opsonin that was either heat-labile itself
or was deposited by a heat-labile system of proteins such as complement. To
further define this, we studied the adherence of L. pneumophila that had been
heated to 56°C for 30 min after opsonization in fresh, nonimmune serum.
L. pneumophila Bacteria per monocyte Inhibition of
(mean ± SD) adherence*
Preopsonized 3.45 ± 0.12 -
Unopsonized 0.19 ± 0.03 95
Serum Bacteria per monocyte
(mean ± SD)
Inhibition of
adherence*
Fresh serum 4.23 t 0.21
Heat-inactivated serum 0.64 ± 0.18 85
No serum 0.11 ± 0.03 97PAYNE AND HORWITZ
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FIGURE 2.
￿
Inhibition of intracellular multiplication ofL. pneu-
mophila by mAbs directed against monocyte membrane CRI or
CR3 receptorswhich recognizethe third component ofcomple-
ment. Monocyte monolayers were incubatedwith mAbs for 30
min at 37°C before infection with L. pneumophila. CFU of L.
pneumophila in the cultures were assayed immediately after
infection and daily thereafter for 2 d. Data are the mean t SE
for triplicate cultures and representative of two separate exper-
iments.
Monocytes bound heat-treated, preopsonized L. pneumophila (0.34 ± 0.12 bac-
teria per monocyte) as avidly as untreated preopsonized L. pneumophila (0.34 ±
0.23 bacteria per monocyte). Therefore, heat inactivation of serum decreases
the deposition of serum opsonins but does not alter them after they have bound
to the bacterial surface.
These experiments were consistent with the hypothesis that fragments of
complement component C3 are the primary ligands recognized by CRI and CR3
and that these ligands mediate adherence ofL. pneumophilato monocytes. Recent
studies from this laboratory (20) have demonstrated by ELISA and by Western
blot analysis that fragments ofcomplement component C3 fix to the L. pneumo-
phila surface when the bacteria are incubated with fresh nonimmune serum;
relatively little C3 fixes to the bacterialsurface in thepresence ofheat-inactivated
serum.
mAbs Against Monocyte CRI and CR3 Receptors Inhibit L. pneumophila Intracel-
lular Multiplication. Since L. pneumophila multiplication is exclusively intracel-
lular under tissue culture conditions, mAbs that inhibit L. pneumophila phago-
cytosis should also inhibit multiplication in monocytes by decreasing bacterial
access to the intracellular milieu of monocytes. We tested this hypothesis by
adding mAbs against CRI and CR3 receptors to monocyte cultures before
infecting the monocytes with L. pneumophila (Fig. 2). Indeed, in the presence of
mAb against the CR3 receptor (1312 or OKM1) or the CRI receptor, L.
pneumophila multiplication in monocyte monolayers was strongly inhibited. The
presence of large amounts (168 jAg/ml) of nonspecific mouse IgG had no
inhibitory effect on L. pneumophila multiplication. These results provided an
independent confirmation of the adherence assay used above.
To determine if mAbs against CR1 or CR3 receptors inhibit intracellular
multiplication ofL. pneumophila that have already been ingested, we added the
mAbs to monocyte monolayers after the monocytes were infected. Addition of
mAbs under these conditions resulted in no decrease in intracellular multiplica-
tion of ingested bacteria, indicating that mAbs have no effect on bacterial
multiplication after the bacteria are internalized.
Paralleling these results, monocyte monolayers infected with L. pneumophila
in thepresence ofanti-CR1 andanti-CR3 mAbs were protected from destruction.1386
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3 d after infection, control monocyte monolayers were completely destroyed
whereas monocyte monolayers treated with the anti-CR1 and with anti-CR3
receptor antibodies remained intact.
Discussion
This study demonstrates that monocyte CR1 and CR3 receptors mediate
phagocytosis of L. pneumophila. The extent to which these receptors mediate
phagocytosis of other bacterial intracellular pathogens is unknown. However,
preliminary studies indicate thatcomplement receptors and complementmediate
phagocytosis ofMycobacterium tuberculosis (21). CR3 as wellasLFA-1 andp150,95
antigens have been shown to bind E. coli (22) and Histoplasma capsulatum (23).
Furthermore, monocyte CR3 and mannosyl-fucosyl receptors have been shown
to mediate phagocytosis ofpromastigotes ofthe intracellular parasite Leishmania
donovani (24) . Thus, complement receptors may play a general role in mediating
phagocytosis ofintracellular pathogens.
Whether monocyte complement receptors play a role in inducing the coiling
phenomenon that characterizes phagocytosis of L. pneumophila is unclear. Inter-
estingly, ingestion of L. donovani promastigotes, which as noted above involves
complement receptors, may take place by coiling phagocytosis. The whorls of
macrophage membranes seen with phagocytosis of L. donovani and originally
attributed to flagellar motion may instead reflect coiling phagocytosis (25).
Equally intriguing, ingestion of Candida albicans may take place by coiling
phagocytosis, at least under certain circumstances (26), and involve complement
receptors. Recently, this organism has been found to have a CR3-like molecule
on its surface (16). Thus, complement receptors may be involvedin inducing the
coiling phenomenon .
mAbs against either CR1 or CR3 receptors strongly inhibited L. pneumophila
adherence and the simultaneous addition ofmAbs against both ofthese receptors
resulted in little or no additional inhibition (Table I1).
mAbs against CR3 and CR1 receptors are not known to crossreact. Possibly,
the CR1 and CR3 receptors are functionally linked in ways not yet understood
or both receptors may be required for phagocytosis of L. pneumophila. Along
these lines, Blackwell et al. (24) reported that two receptors are involved in the
phagocytosis of L. donovani. Inhibition of either the CR3 or mannosyl-fucosyl
receptors strongly inhibited L. donovani adherence and the two antibodies
together were not more inhibitory than either antibody alone (24).
In this study, three mAbs directed against the CR3 receptor inhibited L.
pneumophila adherence. In previous studies, two of these antibodies, OKM-10
and Leu-15, have been shown to inhibit rosetting of complement-coated eryth-
rocytes, but the third antibody, OKM-1, has had variable inhibitory effects on
erythrocyte rosetting. Interestingly, OKM-1 had the least inhibitory effect on L.
pneumophila adherence of the three antibodies (64 ± 8%), but the degree of
inhibition was highly significant in comparison to control antibodies (Table 11, p
< 0.01, unpaired t test).
Monocytes and nonactivated macrophages bind but do not ingest complement-
coated erythrocytes. However, the situation with erythrocytes may not be gen-
erally applicable to microbes. Monocytes readily ingest complement-coated en-PAYNE AND HORWITZ
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capsulated E. coli in the absence of IgG; ingestion of this encapsulated E. coli is
strictlydependent on serum ligands (27). Moreover, inthe case ofL. pneumophila,
it is possible that receptors in addition to complement receptors participate in
phagocytosis.
C3 from two sources, heat-inactivated serum and monocytes, may have been
involvedin modulating CR1 andCR3 receptors in thepresence ofL. pneumophila
membranes. Heat-inactivated serum retains a low but significant capacity to fix
C3 to L. pneumophila (20). Monocytes secrete complement components of the
alternative pathway and C3 from this source may fix to an appropriate target
(10).
The complement receptor pathway may be a preferred route of entry for
intracellular parasites. Under conditions in which complement receptors for C3b
and ON mediate phagocytosis, ligation of these receptors does not consistently
result in release ofsuperoxide, hydrogen peroxide, or mediatorsofinflammation
such as arachidonic acid (28-30). Thus, entry via complement receptors may
allow intracellular parasites to avoid the adverse consequences of the metabolic
oxidative burst. Along these lines, Toxoplasma gondii has been shown to enter
phagocytes without eliciting an oxidative burst (31), although it is not known
whether CR1 or CR3 receptors play a role in phagocytosis of this organism . L.
pneumophila, T. gondii, and C. psittaci may share a common pathway in mono-
nuclear phagocytes (32, 33). All three organisms reside in phagosomes lined by
mitochondria at one stage, all three inhibit phagosome-lysosome fusion, and at
least two (L. pneumophila and T. gondii) inhibit phagosome acidification. It
therefore seems possible that these or other intracellular parasites also share
common entry mechanisms.
Summary
We have examined receptors mediating phagocytosis of the intracellular bac-
terial pathogen, Legionella pneumophila. Three mAbs against the type 3 comple-
ment receptor (CR3), which recognizes C3bi, inhibit adherence of L. pneumophila
to monocytes by 64 ± 8% to 74 ± 11%. An mAb against the type 1 complement
receptor (CR1), which recognizes C3b, inhibits adherence by 68 ± I%. mAbs
against other monocyte surface antigens do not significantly influence adherence.
Monocytes plated on substrates of L. pneumophila membranes modulate their
CR1 and CR3 receptors but not Fc receptors; such monocytes bind 70% fewer
C3b-coated erythrocytes and 53% fewer C3bi-coated erythrocytes than control
monocytes. Adherence of L. pneumophila to monocytes in nonimmune sera is
dependent on heat-labile serum opsonins; adherence is markedly reduced in
heat-inactivated serum (84% reduction) or buffer alone (97% reduction) com-
pared with fresh serum. mAbs against CR1 and CR3 receptors also inhibit L.
pneumophia intracellular multiplication and protect monocyte monolayers from
destruction by this bacterium. This study demonstrates that human monocyte
complement receptors, CR1 and CR3, mediate phagocytosis of L. pneumophila.
These receptorsmay playageneral role inmediatingphagocytosis ofintracellular
pathogens.
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